
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
United-Guardian Inc (UG)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: UG (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 14.01% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 44.61M USD | Price to earnings Ratio 12.78 | 1Y Target Price - |
Price to earnings Ratio 12.78 | 1Y Target Price - | ||
Volume (30-day avg) 9064 | Beta 0.81 | 52 Weeks Range 6.92 - 15.74 | Updated Date 03/30/2025 |
52 Weeks Range 6.92 - 15.74 | Updated Date 03/30/2025 | ||
Dividends yield (FY) 4.89% | Basic EPS (TTM) 0.76 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-03-20 | When Before Market | Estimate - | Actual 0.1096 |
Profitability
Profit Margin 26.37% | Operating Margin (TTM) 32.88% |
Management Effectiveness
Return on Assets (TTM) 17.77% | Return on Equity (TTM) 28.72% |
Valuation
Trailing PE 12.78 | Forward PE - | Enterprise Value 32639279 | Price to Sales(TTM) 3.45 |
Enterprise Value 32639279 | Price to Sales(TTM) 3.45 | ||
Enterprise Value to Revenue 2.68 | Enterprise Value to EBITDA 8.72 | Shares Outstanding 4594320 | Shares Floating 2922630 |
Shares Outstanding 4594320 | Shares Floating 2922630 | ||
Percent Insiders 36.39 | Percent Institutions 23.65 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
United-Guardian Inc
Company Overview
History and Background
United-Guardian Inc. (UG) was founded in 1942. It initially focused on manufacturing pharmaceuticals and has since evolved into a personal care and pharmaceutical ingredient supplier. The company has a long history of innovation in specialty ingredients.
Core Business Areas
- Personal Care Ingredients: United-Guardian develops and manufactures cosmetic and personal care ingredients, focusing on mild and effective products.
- Pharmaceutical Ingredients: UG also produces ingredients used in over-the-counter (OTC) pharmaceutical products.
Leadership and Structure
United-Guardian's leadership team consists of experienced executives in the chemical and pharmaceutical industries. It operates with a relatively flat organizational structure, promoting innovation and responsiveness.
Top Products and Market Share
Key Offerings
- Lubrajel Oil: Lubrajel Oil is a water-soluble emollient used in cosmetics and personal care products. It provides moisturizing and conditioning properties. Market share is difficult to pinpoint precisely, but it is a well-recognized product in its niche. Competitors include companies offering similar water-soluble emollients from various sources (synthetic and natural).
- Cosmetic Antioxidants: United-Guardian also creates other antioxidants for cosmetics. Competitors include BASF (BASFY) and Evonik (EVKIF) and many others.
Market Dynamics
Industry Overview
The personal care and pharmaceutical ingredient industries are characterized by innovation, regulatory compliance, and competition. Demand is driven by consumer trends, technological advancements, and healthcare needs.
Positioning
United-Guardian is a niche player focusing on specialty ingredients and formulations. Its competitive advantages stem from its established reputation, proprietary technologies, and focus on customer service.
Total Addressable Market (TAM)
The global personal care ingredients market is estimated to be worth billions of USD. United-Guardian targets specific niches within this market, such as water-soluble emollients and preservative boosters, indicating a smaller but specialized portion of the overall TAM.
Upturn SWOT Analysis
Strengths
- Established reputation
- Proprietary technologies
- Focus on customer service
- Specialized product portfolio
- Strong cash position
Weaknesses
- Small market capitalization
- Limited product diversification
- Dependence on a few key products
- Low trading volume
- Lack of analyst coverage
Opportunities
- Expanding into new geographic markets
- Developing new specialty ingredients
- Acquiring complementary businesses
- Capitalizing on growing demand for natural and sustainable ingredients
- Increased research and development spending
Threats
- Increased competition from larger players
- Fluctuations in raw material costs
- Changes in regulatory requirements
- Economic downturns
- Emergence of disruptive technologies
Competitors and Market Share
Key Competitors
- BASF (BASFY)
- Evonik (EVKIF)
- Ashland (ASH)
Competitive Landscape
United-Guardian faces competition from larger, more diversified companies with greater resources. UGu2019s focus on niche markets and proprietary technologies allows it to compete effectively.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends would require reviewing United-Guardian's past financial performance.
Future Projections: Analyst estimates for United-Guardian's future growth are generally limited due to its small market capitalization and lack of widespread coverage.
Recent Initiatives: Recent strategic initiatives would need to be gathered from United-Guardian's press releases and investor communications.
Summary
United-Guardian is a niche player with a strong history of innovation in specialty ingredients. Its strengths include its established reputation, proprietary technologies, and focus on customer service. However, its small market capitalization, limited product diversification, and dependence on a few key products pose challenges. The company needs to capitalize on opportunities such as expanding into new markets and developing new ingredients to ensure future growth.
Similar Companies

ASH

Ashland Global Holdings Inc



ASH

Ashland Global Holdings Inc
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Financial News Outlets
- AI Analysis
Disclaimers:
The information provided is for informational purposes only and should not be construed as financial advice. Market share data and financial metrics are estimates based on available information. Investing in stocks involves risks, including the potential loss of capital.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About United-Guardian Inc
Exchange NASDAQ | Headquaters Hauppauge, NY, United States | ||
IPO Launch date 1992-03-17 | CEO - | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 24 | Website https://www.u-g.com |
Full time employees 24 | Website https://www.u-g.com |
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.